Latest News
-
AVI BioPharma Announces FDA Clearance of IND Applications for Clinical Trials of RNA Therapeutic Agents for Treatment of Ebola and Marburg Viruses
December 23, 2008, PORTLAND, Ore.
-
AVI BioPharma Strengthens its Patent Position in RNA Therapeutics
December 23, 2008, PORTLAND, Ore.
-
AVI BioPharma to Present at FDA Public Hearing Regarding Priority Review Vouchers
December 11, 2008, PORTLAND, Ore.
-
AVI BioPharma Files IND for Clinical Trial of Marburg Virus Treatment
December 3, 2008, PORTLAND, Ore.
-
AVI BioPharma Files IND for Clinical Trial of Ebola Virus Treatment
December 3, 2008, PORTLAND, Ore.
About AVI BioPharma
Technology
Communication